Form 4 for GILD Gilead Sciences
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-28 · accession 0001771814-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-01 | 2025-11-28 | GILD | Bluestone Jeffrey | Dir | S - Sale+OE | $125.08 | -5,000 | 8,920 | -36% | -$625.4K |
| D | 2025-12-01 | 2025-11-28 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $64.92 | +5,000 | 13.9K | +56% | +$324.6K |
| D | 2025-12-01 | 2025-11-28 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $0.00 | -5,000 | 7,648 | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | S | D | 5,000 | $125.08 | 8,920 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-28 | M | A | 5,000 | $64.92 | 13,920 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-28 | M | D | 5,000 | $0.00 | 7,648 | D | $64.92 · — to 2034-05-08 | 5,000 Common Stock | (F1) 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024. |